Chair of Pharmacology, Section of Medicine, University of Fribourg, Switzerland.
Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece.
Pharmacol Res. 2020 Nov;161:105119. doi: 10.1016/j.phrs.2020.105119. Epub 2020 Aug 8.
Hydrogen sulfide (HS) is now recognized as an endogenous signaling gasotransmitter in mammals. It is produced by mammalian cells and tissues by various enzymes - predominantly cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST) - but part of the HS is produced by the intestinal microbiota (colonic HS-producing bacteria). Here we summarize the available information on the production and functional role of HS in the various cell types typically associated with innate immunity (neutrophils, macrophages, dendritic cells, natural killer cells, mast cells, basophils, eosinophils) and adaptive immunity (T and B lymphocytes) under normal conditions and as it relates to the development of various inflammatory and immune diseases. Special attention is paid to the physiological and the pathophysiological aspects of the oral cavity and the colon, where the immune cells and the parenchymal cells are exposed to a special "HS environment" due to bacterial HS production. HS has many cellular and molecular targets. Immune cells are "surrounded" by a "cloud" of HS, as a result of endogenous HS production and exogenous production from the surrounding parenchymal cells, which, in turn, importantly regulates their viability and function. Downregulation of endogenous HS producing enzymes in various diseases, or genetic defects in HS biosynthetic enzyme systems either lead to the development of spontaneous autoimmune disease or accelerate the onset and worsen the severity of various immune-mediated diseases (e.g. autoimmune rheumatoid arthritis or asthma). Low, regulated amounts of HS, when therapeutically delivered by small molecule donors, improve the function of various immune cells, and protect them against dysfunction induced by various noxious stimuli (e.g. reactive oxygen species or oxidized LDL). These effects of HS contribute to the maintenance of immune functions, can stimulate antimicrobial defenses and can exert anti-inflammatory therapeutic effects in various diseases.
硫化氢(HS)现在被认为是哺乳动物中的内源性信号气体递质。它由哺乳动物细胞和组织通过各种酶产生 - 主要是半胱氨酸 β-合酶(CBS)、胱硫醚 γ-裂解酶(CSE)和 3-巯基丙酮酸硫转移酶(3-MST) - 但一部分 HS 是由肠道微生物群(结肠 HS 产生菌)产生的。在这里,我们总结了有关 HS 在各种通常与先天免疫(中性粒细胞、巨噬细胞、树突状细胞、自然杀伤细胞、肥大细胞、嗜碱性粒细胞、嗜酸性粒细胞)和适应性免疫(T 和 B 淋巴细胞)相关的细胞类型中的产生和功能作用的现有信息。特别关注口腔和结肠的生理和病理生理方面,由于细菌 HS 的产生,免疫细胞和实质细胞暴露在特殊的“HS 环境”中。HS 有许多细胞和分子靶标。免疫细胞被内源性 HS 产生和来自周围实质细胞的外源性 HS 产生所产生的“HS 云”所“包围”,这反过来又重要地调节它们的活力和功能。在各种疾病中下调内源性 HS 产生酶,或 HS 生物合成酶系统的遗传缺陷,要么导致自发性自身免疫疾病的发展,要么加速各种免疫介导的疾病(例如自身免疫性类风湿关节炎或哮喘)的发作和恶化。通过小分子供体以低、调节量的 HS 可改善各种免疫细胞的功能,并保护它们免受各种有害刺激(例如活性氧或氧化 LDL)引起的功能障碍。HS 的这些作用有助于维持免疫功能,可以刺激抗菌防御,并在各种疾病中发挥抗炎治疗作用。